肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

p89c-Mybex9b是c-Myb的一种选择性剪接形式,其表达是表达p210BCR/ABL细胞增殖和存活所必需的

Expression of p89c-Mybex9b, an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells

原文发布日期:2012-05-11

DOI: 10.1038/bcj.2012.16

类型: Original Article

开放获取: 是

英文摘要:

摘要翻译: 

原文链接:

文章:

p89c-Mybex9b是c-Myb的一种选择性剪接形式,其表达是表达p210BCR/ABL细胞增殖和存活所必需的

Expression of p89c-Mybex9b, an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells

原文发布日期:2012-05-11

DOI: 10.1038/bcj.2012.16

类型: Original Article

开放获取: 是

 

英文摘要:

The c-Myb gene encodes the p75c-Myb isoform and less-abundant proteins generated by alternatively spliced transcripts. Among these, the best known is p89c-Mybex9b, which contains 121 additional amino acids between exon 9 and 10, in a domain involved in protein–protein interactions and negative regulation. In hematopoietic cells, expression of p89c-Mybex9b accounts for 10–15% of total c-Myb; these levels may be biologically relevant because modest changes in c-Myb expression affects proliferation and survival of leukemic cells and lineage choice and frequency of normal hematopoietic progenitors. In this study, we assessed biochemical activities of p89c-Mybex9b and the consequences of perturbing its expression in K562 and primary chronic myeloid leukemia (CML) progenitor cells. Compared with p75c-Myb, p89c-Mybex9b is more stable and more effective in transactivating Myb-regulated promoters. Ectopic expression of p89c-Mybex9b enhanced proliferation and colony formation and reduced imatinib (IM) sensitivity of K562 cells; conversely, specific downregulation of p89c-Mybex9b reduced proliferation and colony formation, enhanced IM sensitivity of K562 cells and markedly suppressed colony formation of CML CD34+ cells, without affecting the levels of p75c-Myb. Together, these studies indicate that expression of the low-abundance p89c-Mybex9b isoform has an important role for the overall biological effects of c-Myb in BCR/ABL-transformed cells.

 

摘要翻译: 

c-Myb基因编码p75c-Myb亚型及通过可变剪接转录本产生的少量其他蛋白。其中最为人熟知的是p89c-Mybex9b,该亚型在第9和第10外显子之间包含额外121个氨基酸,该区域参与蛋白质相互作用及负向调控。在造血细胞中,p89c-Mybex9b的表达量约占c-Myb总表达量的10-15%;这一水平可能具有生物学意义,因为c-Myb表达的微小变化就会影响白血病细胞的增殖存活、正常造血祖细胞的谱系选择与出现频率。本研究评估了p89c-Mybex9b的生化活性及其在K562细胞和原代慢性髓系白血病(CML)祖细胞中表达扰动的影响。与p75c-Myb相比,p89c-Mybex9b具有更高稳定性,在反式激活Myb调控启动子时更有效。异位表达p89c-Mybex9b可增强K562细胞增殖和集落形成能力并降低其对伊马替尼(IM)的敏感性;相反,特异性下调p89c-Mybex9b能抑制K562细胞增殖和集落形成、增强其对IM的敏感性,并显著抑制CML CD34+细胞的集落形成,且不影响p75c-Myb水平。这些研究共同表明,低丰度p89c-Mybex9b亚型的表达对c-Myb在BCR/ABL转化细胞中的整体生物学效应具有重要作用。

 

原文链接:

Expression of p89c-Mybex9b, an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……